Cargando…

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease

Biomarkers and disease-modifying therapies are both urgent unmet medical needs in the treatment of Parkinson’s disease (PD) and must be developed concurrently because of their interdependent relationship: biomarkers for the early detection of disease (i.e., prior to overt neurodegeneration) are nece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polissidis, Alexia, Petropoulou-Vathi, Lilian, Nakos-Bimpos, Modestos, Rideout, Hardy J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355671/ https://www.ncbi.nlm.nih.gov/pubmed/32560161 http://dx.doi.org/10.3390/biom10060912

Ejemplares similares

Imperatorin Influences Depressive-like Behaviors: A Preclinical Study on Behavioral and Neurochemical Sex Differences
por: Kowalczyk, Joanna, et al.
Publicado: (2022)

Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts
por: Petropoulou-Vathi, Lilian, et al.
Publicado: (2022)

Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk
por: Ré, Diane B., et al.
Publicado: (2023)

The politics of EU diaspora in the UK post-Brexit: civic organisations’ multi-scalar lobbying and mobilisation strategies
por: Vathi, Zana, et al.
Publicado: (2023)

The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease
por: Rideout, Hardy J., et al.
Publicado: (2020)

Off-Target Effects of Antidepressants on Vascular Function and Structure
por: Dimoula, Anna, et al.
Publicado: (2021)

Early Signs of Pathological Cognitive Aging in Mice Lacking High-Affinity Nicotinic Receptors
por: Konsolaki, Eleni, et al.
Publicado: (2016)

Future Therapeutic Strategies for Freezing of Gait in Parkinson’s Disease
por: Cui, Cathy K., et al.
Publicado: (2021)

LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease
por: Wojewska, Dominika Natalia, et al.
Publicado: (2021)

Social Connection, (Im)material Gains and Experiences of Inclusion of Asylum Seekers’ and Refugees’ Volunteering in Glasgow
por: Ramachandran, Niroshan, et al.
Publicado: (2022)

The Future of Surgical Treatments for Parkinson’s Disease
por: Lee, Darrin J., et al.
Publicado: (2018)

Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy
por: Venezia, Serena, et al.
Publicado: (2017)

MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
por: Arshad, Ahmad R., et al.
Publicado: (2017)

miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s disease
por: Liu, Xiaoting, et al.
Publicado: (2019)

Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus
por: Nikolopoulos, Dionysis, et al.
Publicado: (2023)

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
por: Fiandaca, Massimo S., et al.
Publicado: (2012)

Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson’s Disease
por: Siddiqui, Talha, et al.
Publicado: (2023)

Editorial Introduction: The Shifting Geopolitics of Return Migration and Reintegration
por: Vathi, Zana, et al.
Publicado: (2022)

Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies
por: Ekblad‐Nordberg, Åsa, et al.
Publicado: (2019)

Correction to: miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s disease
por: Liu, Xiaoting, et al.
Publicado: (2019)

The κ-opioid receptor-induced autophagy is implicated in stress-driven synaptic alterations
por: Karoussiotis, Christos, et al.
Publicado: (2022)

Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014)

Retinal age gap as a predictive biomarker of future risk of Parkinson’s disease
por: Hu, Wenyi, et al.
Publicado: (2022)

Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
por: Gouda, Noha A., et al.
Publicado: (2022)

Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
por: Emamzadeh, Fatemeh N., et al.
Publicado: (2018)

Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats
por: Delis, Foteini, et al.
Publicado: (2016)

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
por: Iarkov, Alexandre, et al.
Publicado: (2020)

Chronic Pain Treatment Strategies in Parkinson’s Disease
por: Edinoff, Amber, et al.
Publicado: (2020)

Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
por: Nie, Shiqing, et al.
Publicado: (2022)

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
por: Tönges, Lars, et al.
Publicado: (2022)

Fear Conditioning by Proxy: The Role of High Affinity Nicotinic Acetylcholine Receptors
por: Chalkea, Zinovia Stavroula, et al.
Publicado: (2023)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
por: Curry, Daniel W., et al.
Publicado: (2018)

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
por: Gundersen, Vidar
Publicado: (2021)

Strategies targeting endoplasmic reticulum stress to improve Parkinson’s disease
por: Wang, Danni, et al.
Publicado: (2023)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

Current diagnostics and treatment of fibrosarcoma –perspectives for future therapeutic targets and strategies
por: Augsburger, Daniela, et al.
Publicado: (2017)

Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
por: Mao, Qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sns9trc84sn8l64i2oihntlchb